FibroBiologics, Inc. (FBLG) stock
FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.90−0.00 (-0.32%)
Close on Nov 17, 2026Market cap $6.00MP/E –Yield –
FibroBiologics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
FibroBiologics's enterprise value was $271.04K on Nov 11, 2026, against $5.58M a year earlier. Over the last 3 years it ranged from -$1.95M to $819.25M, with a median of $13.16M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $271.04K | -92.7% |
| 2025 | Dec 31, 2025 | $3.71M | -93.3% |
| 2024 | Dec 31, 2024 | $54.97M | – |
See a number that looks wrong?